Bausch & Lomb Incorporated

Bausch & Lomb Incorporated Overview

Company Headquarters: New Jersey, US

Founded: 1853

Workforce: 20,000+

Company Working: Bausch & Lomb Incorporated develops, manufactures, and markets eye care products. The company’s products include contact lens and lens care products, such as chemical disinfectants for soft contact lenses, Boston line of products, and prescription pharmaceutical medicines to treat eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye, and retinal diseases, among others.

Moreover, it also offers contract manufacturing services for sterile and non-sterile solutions, suspensions, ointments, gels, creams, nasals, and injectables. It is headquartered in the US and has additional offices in Argentina, Australia, Austria, Belgium, Bulgaria, Brazil, Canada, China, the Czech Republic/Slovakia, Dubai, France, Germany, Greece, and Hong Kong, among others. Bausch & Lomb Incorporated operates as a subsidiary of Bausch Health Companies Inc.

Strategy

Bausch & Lomb Incorporated's goal is to become a leading, focused pharmaceutical business via the development of novel therapeutic platforms and data science. It focuses on improving its commercial effectiveness in order to better meet the needs of its clients. In order to increase its market share, it also concentrates on product approvals, the purchase and divestment of goods or whole companies, and the establishment of strategic alliances and collaborations. Furthermore, Bausch & Lomb Incorporated has focused its resources on important growth brands and launches, developing next-generation initiatives, and investing in technology platforms while being at the forefront of medication development in novel drugs.

Company Snapshot

$8,601M

Revenue

20,000

Employees

1853

Founded

New Jersey, US

Headquarters

SWOT Analysis

Strengths

One of the largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products.
Presence in more than 36 countries worldwide
High growth in the business
Strong presence in the US and Canada
Innovative product portfolio
Focus on marketing and sales
Constitutes a strong distribution network
Well established research and development facilities
Brand reputation
Strong competency in acquisitions

Weaknesses

Revenue dependence on the US
Management issues and complexities
Limited presence in emerging markets
Previous controversies and ongoing legal proceedings may negatively affect the company’s image
Primary focus on the US market

Opportunities

Partnering with local key players
Expansion in the range of products
Strategic investments in mergers & acquisitions to increase product portfolio
New product launches to expand the product portfolio
Collaborations and joint ventures

Threats

Worsening regulatory environment in the US
High competition
High price-sensitivity of consumers
International business risk

Key Developments

Date	Approach	Development
October 2019	Product Launch	Bausch & Lomb Incorporated announced the US launch of PreserVision AREDS 2 Formula minigel eye vitamins. Thus, the company aims to expand its target audience in the US eye health supplements market.
July 2019	Product Launch	Bausch & Lomb Incorporated announced the US launch of Ocuvite Eye Performance, an eye vitamin supplement formulated with seven vital nutrients that helps strengthen the macula and protects the eye from the stress of sunlight and blue light emitted from digital devices. This new offering was created to meet the changing needs of consumers while further expanding the company’s eye vitamin portfolio.
February 2019	Website Launch	Bausch & Lomb Incorporated launched SightMatters.com, a new educational online resource for people living with age-related macular degeneration (AMD).
June 2018	Product Launch	Bausch & Lomb Incorporated introduced Ocuvite Blue Light eye vitamins, a nutritional supplement formulated with lutein and zeaxanthin.
May 2018	Product Launch	The company introduced PreserVision AREDS 2 Formula chewable vitamins, which were designed to meet the growing consumer preference for chewable tablets.
September 2017	Product Launch	The company launched Ocuvite Adult 50+ Formula Minigel daily eye vitamins that help replenish vital nutrients that eyes can lose as they age. With this, the company expanded its product portfolio.

Product Offering

BAUSCH & LOMB INCORPORATED
- Vitamins for General Eye Health
- Eye Health Supplements

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.